Monday, June 16, 2025
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
    Navigating the Medical Licensing Maze

    Navigating the Medical Licensing Maze

    April 4, 2025
    The Alarming Truth About Health Insurance Denials

    The Alarming Truth About Health Insurance Denials

    February 3, 2025
    Telehealth in Turmoil

    The Importance of NIH Grants

    January 31, 2025
    The New Era of Patient Empowerment

    The New Era of Patient Empowerment

    January 29, 2025
    Physicians: Write Thy Briefs

    Physicians: Write thy amicus briefs!

    January 26, 2025
  • Surveys

    Surveys

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    June 4, 2025
    Understanding Public Perception and Awareness of Medicare Advantage and Payment Change

    Understanding Public Perception and Awareness of Medicare Advantage and Payment Change

    April 4, 2025

    Survey Results

    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
    Navigating the Medical Licensing Maze

    Navigating the Medical Licensing Maze

    April 4, 2025
    The Alarming Truth About Health Insurance Denials

    The Alarming Truth About Health Insurance Denials

    February 3, 2025
    Telehealth in Turmoil

    The Importance of NIH Grants

    January 31, 2025
    The New Era of Patient Empowerment

    The New Era of Patient Empowerment

    January 29, 2025
    Physicians: Write Thy Briefs

    Physicians: Write thy amicus briefs!

    January 26, 2025
  • Surveys

    Surveys

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report

    June 4, 2025
    Understanding Public Perception and Awareness of Medicare Advantage and Payment Change

    Understanding Public Perception and Awareness of Medicare Advantage and Payment Change

    April 4, 2025

    Survey Results

    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

The Great COVID Vaccine Bet

Daily Remedy by Daily Remedy
May 30, 2022
in Contrarian
0
The Great COVID Vaccine Bet

Every gambler will tell you before placing a bet, there is a moment of doubt. It is natural. After all, it is human nature to be cautious of the unknown. And when confronted with uncertainty, we calculate what we believe to be the odds.

Inevitably, this is a subjective exercise. We all perceive risk differently. So the odds are unique to each individual. To compound matters further, not only do we look at risk differently, risk itself changes overtime. It does not take long before the entire process of prediction breaks down into chaos.

This is where we find those at the CDC (Centers for Disease Control & Prevention) in charge of COVID vaccine policies, mulling constantly changing odds that were never fully understood to begin with. As a result, we have those who will jump the line to take any number of booster doses. And we have those who steadfastly refuse to even discuss the topic of vaccines.

But even the most vaccine-happy of us are growing a sense of fatigue with the never ending calls for boosters. It is a sentiment keenly observed among policymakers at the CDC.

“We don’t feel comfortable with multiple boosters every 8 weeks,” said Vaccines and Related Biological Products Advisory Committee Chairman Arnold Monto, MD. “We’d love to see an annual vaccination similar to influenza but realize that the evolution of the virus will dictate how we respond in terms of additional vaccine doses,” he continued.

Simply put, policymakers previously called for additional boosters because they did and still do not know how the virus evolves. And instead of risking more severe infections, the CDC would rather risk its own credibility in calling for more boosters.

We are now at the point where those calls ring hollow. And the CDC has no option but to confront the uncomfortable reality in which it finds itself.

The current vaccines are waning in efficiency along with the public’s trust in CDC recommendations. Next generation, annualized COVID vaccines will likely be available in the Fall, in time for another surge in viral cases, but we are not sure whether they will work – even if they are here.

The CDC has to decide what it will do. It has to place a bet. Should it invest clinical resources and promote public messaging in favor of next generation vaccines; or should it continue along the lines of advocating for more and more boosters?

To determine the best course of action, we should calculate the odds – make a bet. There are two factors at hand with the next generation COVID vaccines. First, will they be ready in time? Second, will they work effectively enough to be good for a full year?

Vaccine stalwarts Pfizer and Moderna have already developed their own versions of a next generation vaccine. Pfizer CEO Albert Bourla said it would be ready to start manufacturing doses of its next generation vaccine as soon as it receives guidance from the FDA. Moderna CEO Stephane Bancel announced its next generation vaccine will be ready by the Fall, and already has data to boot.

“We look forward to sharing initial data on mRNA-1273.214 later in the second quarter [of 2022]. We believe that a bivalent booster vaccine if authorized would create a new tool as we continue to respond to emerging variants”, said Bourla.

Internationally, other COVID vaccine manufacturers are also making their move. CureVac and GlaxoSmithKline (GSK) have developed their own version of a next generation COVID vaccine.

It all sounds so promising. Until we confront the hard reality that the vaccines developed might not be as effective as promised. Clearly, we will have next generation, annualized vaccines ready by the Fall. In fact, we will have an abundance of such vaccines.

But these vaccines are all predicated on certain assumptions – certain odds, if you will – about the evolution of COVID. Some of which we know, but others that remain quite unknown.

“There’s still a lot of science that’s not known,” points out Duke Project program officer Jennifer Gordon, an international program aimed at pooling together resources and research efforts to maximize vaccine effectiveness.

According to the Duke Project, scientists study natural immunity to better anticipate how to optimize acquired immunity. The hope is that a better understanding of the natural immune responses to COVID will ultimately yield better vaccine designs.

But there are trade-offs. Although we have limited the mutation patterns to certain spike proteins on the corona virus, we remain unsure of how we should target those spike proteins. Scientists debate whether we should target slower mutating, more predictable proteins that would make for a weaker, but more certain vaccine; or go for the Hail Mary and target the more virulent, mutagenic proteins, at the risk of overall vaccine efficiency.

It is a game of odds in which scientists gamble mutation rates and vaccine formularies. There will always be trade-offs because there will always be uncertainty. And to heighten things further, there are dollars at stake. Manufacturing the next generation of COVID vaccines will not be cheap, and like before, the federal government will foot the bill. Something the White House seems eager to do, despite a shrinking economy and rampant inflation.

Ashish Jha, MD, White House COVID response chief publicly announced his support to fund the next generation vaccines as soon as possible. He warns the current vaccine strategy of recurrent boosters is losing value and will quickly grow obsolete in terms of immunogenicity and public perception. He is clearly correct, but his reasons for being right – as with all things in the pandemic – are a complex mix of science and politics, forming yet another variable for the CDC.

All of which is to say, the CDC has a lot to weigh as it meets in June to decide whether to move forward with the next generation COVID vaccines. It has to balance finance and politics with public perception and vaccine efficiency. It is not an enviable task, but it is the great bet now placed before the CDC.

And with all bets, there will be moments of doubt. But this time, perhaps we should worry less about being wrong, and consider whether we were ever right in the first place.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

Summary

In this episode of the Daily Remedy Podcast, Dr. Joshi discusses the rapidly changing landscape of healthcare laws and trends, emphasizing the importance of understanding the distinction between statutory and case law. The conversation highlights the role of case law in shaping healthcare practices and encourages physicians to engage in legal advocacy by writing legal briefs to influence case law outcomes. The episode underscores the need for physicians to actively participate in the legal processes that govern their practice.

Takeaways

Healthcare trends are rapidly changing and confusing.
Understanding statutory and case law is crucial for physicians.
Case law can overturn existing statutory laws.
Physicians can influence healthcare law through legal briefs.
Writing legal briefs doesn't require extensive legal knowledge.
Narrative formats can be effective in legal briefs.
Physicians should express their perspectives in legal matters.
Engagement in legal advocacy is essential for physicians.
The interpretation of case law affects medical practice.
Physicians need to be part of the legal conversation.
Physicians: Write thy amicus briefs!
YouTube Video FFRYHFXhT4k
Subscribe

MD Angels Investor Pitch

Visuals

Official MAHA Report

Official MAHA Report

by Daily Remedy
May 31, 2025
0

Explore the official MAHA Report released by the White House in May 2025.

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • The First FBI Agent I Met

    3 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • The Southern Signal: Australia’s Flu and COVID Wave Could Foreshadow America’s Next Public Health Crisis

    1 shares
    Share 0 Tweet 0
  • When Influence Turns Deadly: The Cancer Misinformation Crisis on Social Media

    1 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2025 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2025 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do